Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Priapism in Sickle Cell Anemia
source: Family Practice Notebook
year: 2018
summary/abstract:Priapism in Sickle Cell Anemia:
II. Epidemiology
Incidence of Priapism in Sickle Cell Anemia: 89% by age 20 years old
III. Management
Duration: Analgesics
IV Fluids
Do not transfuse for Priapism 4 hours
Administer above measures if not already attempted
Exchange transfusion (Risk of CVA symptoms)
Epidural Anesthesia
Related Content
-
Very Low Incidence of Clostridioides Difficile Infection in Pediatric Sickle Cell Disease PatientsDespite advances in the survival of pedi...
-
The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysisElevated tricuspid regurgitant jet veloc...
-
SCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
Virtual Reality Helps Reduce Pain Among Patients With Sickle Cell DiseaseImmersive virtual reality appeared effec...
-
GBT expands sickle cell disease pipeline with worldwide licensing agreement for inclacumab for the treatment of vaso...Global Blood Therapeutics, Inc...
-
APS Scientific Meeting 2019The American Pain Society will hold its ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.